EOF: Letter to Shareholders

ECOFIBRE LIMITED

• Ecofibre has received patent grant notifications for two of its five applications filed in October 2022 with the USPTO, related to gynecological disorder treatments.
• The granted patents cover treatments for Ovarian Cancer, Endometriosis, Fibroids, and Dysmenorrhea.
• Two additional patent applications for Head and Neck Cancer and Endometrial Cancer remain under review, while a third patent for Ecofibre's proprietary System and Method for Producing Hemp Extracts awaits formal grant notification.

2023-05-11 08:20:00